Loading...

argenx SE

ARGNF•PNK
Healthcare
Biotechnology
$724.55
$-56.45(-7.23%)
U.S. Market opens in 2h 8m

argenx SE (ARGNF) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap44.8B
P/E Ratio20.59
EPS (TTM)$19.60
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$841.14
3 Months$778.81
1 Year Target$887.72

ARGNF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGNF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.66, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $887.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.59 and a market capitalization of 44.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.23%
5-Day Change
-7.23%
1-Month Change
-11.09%
3-Month Change
-13.95%
6-Month Change
-13.07%
Year-to-Date (YTD) Change
-16.72%
1-Year Change
3.89%
3-Year Change
82.36%
5-Year Change
127.58%
All-Time (Max) Change
6989.53%

Contact Information

https://www.argenx.com
31 10 703 8441
Willemstraat 5, Breda, NaN, 4811 AH

Company Facts

1,599 Employees
IPO DateApr 30, 2015
CountryNL
Actively Trading

Frequently Asked Questions